Health News
Revlimid and Risk of New Cancers
The U.S. Food and Drug Administration (FDA) is informing the public of an increased risk of second primary malignancies (new types of cancer) in patients with newly-diagnosed multiple myeloma who received Revlimid ( lenalidomide ).
Certain Vaccines May Help Guard Against Childhood Cancer
Children vaccinated against hepatitis B might be at a lower risk of developing leukemia, according to a new study.